AIMS: Among patients with cardiogenic shock, immediate initiation of extracorporeal membrane oxygenation (ECMO) did not demonstrate any benefit at 30 days. The present study evaluated 1-year clinical outcomes of the Extracorporeal Membrane Oxygenation in the therapy of Cardiogenic Shock (ECMO-CS) trial. METHODS AND RESULTS: The ECMO-CS trial randomized 117 patients with severe or rapidly progressing cardiogenic shock to immediate initiation of ECMO or early conservative strategy. The primary endpoint for this analysis was 1-year all-cause mortality. Secondary endpoints included a composite of death, resuscitated cardiac arrest or implantation of another mechanical circulatory support device, duration of mechanical ventilation, and the length of intensive care unit (ICU) and hospital stays. In addition, an unplanned post-hoc subgroup analysis was performed. At 1 year, all-cause death occurred in 40 of 58 (69.0%) patients in the ECMO arm and in 40 of 59 (67.8%) in the early conservative arm (hazard ratio [HR] 1.02, 95% confidence interval [CI] 0.66-1.58; p = 0.93). The composite endpoint occurred in 43 (74.1%) patients in the ECMO group and in 47 (79.7%) patients in the early conservative group (HR 0.83, 95% CI 0.55-1.25; p = 0.29). The durations of mechanical ventilation, ICU stay and hospital stay were comparable between groups. Significant interaction with treatment strategy and 1-year mortality was observed in subgroups according to baseline mean arterial pressure (MAP) indicating lower mortality in the subgroup with low baseline MAP (<63 mmHg: HR 0.58, 95% CI 0.29-1.16; pinteraction = 0.017). CONCLUSIONS: Among patients with severe or rapidly progressing cardiogenic shock, immediate initiation of ECMO did not improve clinical outcomes at 1 year compared to the early conservative strategy. However, immediate ECMO initiation might be beneficial in patients with advanced haemodynamic compromise.

2nd Department of Medicine Department of Cardiovascular Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Cardiology 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Department of Cardiology Na Homolce Hospital Prague Czech Republic

Department of Cardiology University Hospital and Faculty of Medicine Pilsen Charles University Pilsen Czech Republic

Department of Emergency Medicine 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Hospital Liberec Liberec Czech Republic

Zobrazit více v PubMed

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4–131. https://doi.org/10.1002/ejhf.2333

Thiele H, Akin I, Sandri M, de Waha‐Thiele S, Meyer‐Saraei R, Fuernau G, et al.; CULPRIT‐SHOCK Investigators. One‐year outcomes after PCI strategies in cardiogenic shock. N Engl J Med 2018;379:1699–1710. https://doi.org/10.1056/NEJMoa1808788

Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer‐Saraei R, et al.; CULPRIT‐SHOCK Investigators. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 2017;377:2419–2432. https://doi.org/10.1056/NEJMoa1710261

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022;145:e895–e1032. https://doi.org/10.1161/CIR.0000000000001063

Brunner S, Guenther SPW, Lackermair K, Peterss S, Orban M, Boulesteix AL, et al. Extracorporeal life support in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 2019;73:2355–2357. https://doi.org/10.1016/j.jacc.2019.02.044

Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, et al.; ECMO‐CS Investigators. Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: Results of the ECMO‐CS randomized clinical trial. Circulation 2023;147:454–464. https://doi.org/10.1161/CIRCULATIONAHA.122.062949

Banning AS, Sabate M, Orban M, Gracey J, López‐Sobrino T, Massberg S, et al. Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: The multicentre, randomised EURO SHOCK trial. EuroIntervention 2023;19:482–492. https://doi.org/10.4244/EIJ‐D‐23‐00204

Thiele H, Zeymer U, Akin I, Behnes M, Rassaf T, Mahabadi AA, et al.; ECLS‐SHOCK Investigators. Extracorporeal life support in infarct‐related cardiogenic shock. N Engl J Med 2023;389:1286–1297. https://doi.org/10.1056/NEJMoa2307227

Zeymer U, Freund A, Hochadel M, Ostadal P, Belohlavek J, Rokyta R, et al. Venoarterial extracorporeal membrane oxygenation in patients with infarct‐related cardiogenic shock: An individual patient data meta‐analysis of randomised trials. Lancet 2023;402:1338–1346. https://doi.org/10.1016/S0140‐6736(23)01607‐0

Ostadal P, Rokyta R, Kruger A, Vondrakova D, Janotka M, Smíd O, et al. Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO‐CS): Rationale and design of the multicenter randomized trial. Eur J Heart Fail 2017;19:124–127. https://doi.org/10.1002/ejhf.857

Lackermair K, Brunner S, Orban M, Peterss S, Orban M, Theiss HD, et al. Outcome of patients treated with extracorporeal life support in cardiogenic shock complicating acute myocardial infarction: 1‐year result from the ECLS‐SHOCK study. Clin Res Cardiol 2021;110:1412–1420. https://doi.org/10.1007/s00392‐020‐01778‐8

Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen MM, et al. Coronary angiography after cardiac arrest without ST segment elevation: One‐year outcomes of the COACT randomized clinical trial. JAMA Cardiol 2020;5:1358–1365. https://doi.org/10.1001/jamacardio.2020.3670

Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, Levin H, Ullén S, et al.; TTM2 Trial Investigators. Hypothermia versus normothermia after out‐of‐hospital cardiac arrest. N Engl J Med 2021;384:2283–2294. https://doi.org/10.1056/NEJMoa2100591

Levy B, Girerd N, Amour J, Besnier E, Nesseler N, Helms J, et al.; HYPO‐ECMO Trial Group and the International ECMO Network (ECMONet). Effect of moderate hypothermia vs normothermia on 30‐day mortality in patients with cardiogenic shock receiving venoarterial extracorporeal membrane oxygenation: A randomized clinical trial. JAMA 2022;327:442–453. https://doi.org/10.1001/jama.2021.24776

Sterling LH, Fernando SM, Talarico R, Qureshi D, van Diepen S, Herridge MS, et al. Long‐term outcomes of cardiogenic shock complicating myocardial infarction. J Am Coll Cardiol 2023;82:985–995. https://doi.org/10.1016/j.jacc.2023.06.026

Moller JE, Engstrom T, Jensen LO, Eiskjær H, Mangner N, Polzin A, et al.; DanGer Shock Investigators. Microaxial flow pump or standard care in infarct‐related cardiogenic shock. N Engl J Med 2024;390:1382–1393. https://doi.org/10.1056/NEJMoa2312572

Josiassen J, Lerche Helgestad OK, Moller JE, Kjaergaard J, Hoejgaard HF, Schmidt H, et al. Hemodynamic and metabolic recovery in acute myocardial infarction‐related cardiogenic shock is more rapid among patients presenting with out‐of‐hospital cardiac arrest. PLoS One 2020;15:e0244294. https://doi.org/10.1371/journal.pone.0244294

Nolan JP, Sandroni C, Bottiger BW, Cariou A, Cronberg T, Friberg H, et al. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: Post‐resuscitation care. Resuscitation 2021;161:220–269. https://doi.org/10.1016/j.resuscitation.2021.02.012

Burstein B, Tabi M, Barsness GW, Bell MR, Kashani K, Jentzer JC. Association between mean arterial pressure during the first 24 hours and hospital mortality in patients with cardiogenic shock. Crit Care 2020;24:513. https://doi.org/10.1186/s13054‐020‐03217‐6